Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study

Author： Hildebrandt B.   Wust P.   Dräger J.   Lüdemann L.   Sreenivasa G.   Tullius S. G.   Amthauer H.   Neuhaus P.   Felix R.   Riess H.  

Publisher： Informa Healthcare

ISSN： 1464-5157

Source： International Journal of Hyperthermia, Vol.20, Iss.4, 2004-06, pp. : 359-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

By Zori Comba A.   Blajman C.   Richardet E.   Bella S.   Vilanova M.   Coppola F.   Van Kooten M.   Rodger J.   Giglio R.   Balbiani L.   Perazzo F.   Montiel M.   Chacon M.   Pujol F.   Mickiewicz E.   Cazap E.   Recondo G.   Lastiri F.   Simon J.   Wasserman E.   Schmilovich A.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1006-1013

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Oxaliplatin, Folinic Acid, and 5-Fluorouracil (FOLFOX4) as First-Line Chemotherapy in Advanced Colorectal Cancer: A China Single-Center Experience

By Xu Nong   Fang Wei-Jia   Zhang Xiao-Chen   Yu Lan-Fang   Bao Han-Ying   Shi Gen-Ming   Huang Sui   Shen Peng  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer

By Gunnlaugsson Adalsteinn   Kjellén Elisabeth   Nilsson Per   Bendahl Pär-Ola   Willner Julian   Johnsson Anders  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 937-944

Informa Healthcare

Access to resources Recommend Favorite

High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): A phase I trial

By Vestermark Lene W.   Jensen Helle A.   Pfeiffer Per  

Acta Oncologica, Vol. 51, Iss. 3, 2012-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients

By Bensmane M.A.   de Gramont A.   Brienza S.   Marty M.   Levi F.   Ducreux M.   Francois E.   Gamelin E.   Bleiberg H.   Bleuzen P.   Simon J.   Cvitkovic E.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2335-2343

Elsevier

Access to resources Recommend Favorite